Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingPhase 3IIT 病毒宁滴剂治疗普通感冒(风热证)的随机、双盲双模拟、阳性药/安慰剂平行对照、多中心Ⅲ期临床研究
[Translation] A randomized, double-blind, double-dummy, active drug/placebo parallel-controlled, multicenter phase III clinical study on the treatment of common cold (wind-heat syndrome) with Virus Ning drops
1.确证病毒宁滴剂治疗普通感冒的有效性;
2.进一步评价病毒宁滴剂的安全性及不良反应。
[Translation] 1. Confirm the effectiveness of Virus Ning drops in treating the common cold;
2. Further evaluate the safety and adverse reactions of Virus Ning drops.
病毒宁滴剂治疗普通感冒(风热证)评价其有效性和安全性的随机双盲、安慰剂平行对照、多中心Ⅱ期临床研究
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase II clinical study to evaluate the efficacy and safety of Virus Ning drops in the treatment of common cold (wind-heat syndrome)
以安慰剂为对照,评价病毒宁滴剂治疗普通感冒(风热证)的有效性和安全性,同时初步探索该药抗病毒效果,为Ⅲ期临床设计提供依据。
[Translation] Using placebo as a control, the efficacy and safety of Virus Ning drops in the treatment of common cold (wind-heat syndrome) were evaluated, and the antiviral effect of the drug was preliminarily explored to provide a basis for the Phase III clinical design.
100 Clinical Results associated with Artemisinin Research Center, Guangzhou University of Chinese Medicine
0 Patents (Medical) associated with Artemisinin Research Center, Guangzhou University of Chinese Medicine
100 Deals associated with Artemisinin Research Center, Guangzhou University of Chinese Medicine
100 Translational Medicine associated with Artemisinin Research Center, Guangzhou University of Chinese Medicine